13 May 2019

Just how effective is menopausal hormone therapy?



In a two-part video, find out the effect of MHT on some common symptoms like VMS, sleep disturbances and mood in addition to the long-term impact on osteoporosis-related fractures. Then delve into vaginal and urinary tract symptoms and look at addressing sexual function.

These short videos are part of a series of brief, topical discussions with women’s health authority Dr Terri Foran, in which she takes a practical look at the questions commonly face when you manage a woman with menopausal symptoms.

Some of the other topics in the series include:
• Lifestyle modifications & alternative therapies — Do they really help?
• MHT – Which progesterone? Body identical vs bioidentical
• The risks associated with MHT — Today’s evidence
• MHT in practice
— When to start
— When to finish
— Addressing patient concerns

Watch the full series at

Brought to you by:

Your partner in MHT1

Please review Product Information before prescribing. Approved Product Information is available by clicking here.

MHT, menopausal hormone therapy; VMS, vasomotor symptoms.

1. Prometrium Approved Product Information, 20 June 2016.
Besins Healthcare Australia Pty Ltd. ABN 68 164 882 062. Suite 3, Level 2, Tower 1, 495 Victoria Ave, Chatswood, NSW 2067. Office phone (02) 9904 7473. For medical information call 1800 BESINS (1800 237 467). www.besins-healthcare.com.au PROM0091 Approval date May 2019 B&P ®Prometrium is a registered trademark of Besins Healthcare.


COVID-19 live update